Posaconazole-Loaded Leukocytes as a Novel Treatment Strategy Targeting Invasive Pulmonary Aspergillosis.

Baistrocchi, Shane R; Lee, Mark J; Lehoux, Melanie; Ralph, Benjamin; Snarr, Brendan D; Robitaille, Robert; Sheppard, Donald C

Baistrocchi, Shane R; Lee, Mark J; Lehoux, Melanie; Ralph, Benjamin; Snarr, Brendan D; Robitaille, Robert; Sheppard, Donald C.

Afiliação

Baistrocchi SR; Department of Microbiology and Immunology, McGill University.
Lee MJ; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre.
Lehoux M; Department of Microbiology and Immunology, McGill University.
Ralph B; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre.
Snarr BD; Department of Microbiology and Immunology, McGill University.
Robitaille R; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre.
Sheppard DC; Department of Microbiology and Immunology, McGill University.

J Infect Dis ; 215(11): 1734-1741, 2017 06 01.

Article em En | MEDLINE | ID: mdl-27799353

Assuntos

Antifúngicos/uso terapêutico; Aspergilose Pulmonar Invasiva/tratamento farmacológico; Triazóis/uso terapêutico; Animais; Antifúngicos/farmacologia; Quimiotaxia/efeitos dos fármacos; Feminino; Células HL-60; Humanos; Pulmão/microbiologia; Pulmão/patologia; Camundongos; Camundongos Endogâmicos BALB C; Triazóis/farmacologia

Palavras-chave

Aspergillus fumigatus; HL-60; invasive pulmonary aspergillosis; neutrophil; posaconazole

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Triazóis / Aspergilose Pulmonar Invasiva / Antifúngicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google